Ghaderinezhad, Fariba
Amin, Reza
Temirel, Mikail
Yenilmez, Bekir
Wentworth, Adam
Tasoglu, Savas
Article History
Received: 22 November 2016
Accepted: 28 March 2017
First Online: 15 June 2017
Competing Interests
: S. Tasoglu is founder of, and has an equity interest in: (i) mBiotics, LLC, a company that is developing microfluidic technologies for point-of-care diagnostic solutions. S. Tasoglu’s interests were viewed and managed in accordance with the conflict of interest policies. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.